do Monte-Neto RL - Search Results

1

Planarians as models to investigate the bioactivity of gold(I) complexes in vivo.

Tunes LG, Allen JM, Zayas RM, do Monte-Neto RL. Tunes LG, et al. Sci Rep. 2018 Nov 1;8(1):16180. doi: 10.1038/s41598-018-34558-6. Sci Rep. 2018. PMID: 30385794 Free PMC article.

2

Growth arrested live-attenuated Leishmania infantum KHARON1 null mutants display cytokinesis defect and protective immunity in mice.

Santi AMM, Lanza JS, Tunes LG, Fiuza JA, Roy G, Orfanó ADS, de Carvalho AT, Frézard F, Barros ALB, Murta SMF, do Monte-Neto RL. Santi AMM, et al. Sci Rep. 2018 Aug 2;8(1):11627. doi: 10.1038/s41598-018-30076-7. Sci Rep. 2018. PMID: 30072701 Free PMC article.

3

Preclinical Gold Complexes as Oral Drug Candidates to Treat Leishmaniasis Are Potent Trypanothione Reductase Inhibitors.

Tunes LG, Morato RE, Garcia A, Schmitz V, Steindel M, Corrêa-Junior JD, Dos Santos HF, Frézard F, de Almeida MV, Silva H, Moretti NS, de Barros ALB, do Monte-Neto RL. Tunes LG, et al. ACS Infect Dis. 2020 May 8;6(5):1121-1139. doi: 10.1021/acsinfecdis.9b00505. Epub 2020 Apr 27. ACS Infect Dis. 2020. PMID: 32283915

4

Organogold(III)-dithiocarbamate compounds and their coordination analogues as anti-tumor and anti-leishmanial metallodrugs.

de Andrade Querino AL, de Sousa AM, Thomas SR, de Lima GM, Dittz D, Casini A, do Monte-Neto RL, Silva H. de Andrade Querino AL, et al. Among authors: do monte neto rl. J Inorg Biochem. 2023 Oct;247:112346. doi: 10.1016/j.jinorgbio.2023.112346. Epub 2023 Jul 29. J Inorg Biochem. 2023. PMID: 37536162

5

Susceptibility of Leishmania to novel pentavalent organometallics: Investigating impact on DNA and membrane integrity in antimony(III)-sensitive and -resistant strains.

Islam A, do Prado BR, Dittz D, Rodrigues BL, Silva SMD, do Monte-Neto RL, Shabeer M, Frézard F, Demicheli C. Islam A, et al. Among authors: do monte neto rl. Drug Dev Res. 2024 May;85(3):e22194. doi: 10.1002/ddr.22194. Drug Dev Res. 2024. PMID: 38704828

6

Gene expression profiling and molecular characterization of antimony resistance in Leishmania amazonensis.

do Monte-Neto RL, Coelho AC, Raymond F, Légaré D, Corbeil J, Melo MN, Frézard F, Ouellette M. do Monte-Neto RL, et al. PLoS Negl Trop Dis. 2011 May;5(5):e1167. doi: 10.1371/journal.pntd.0001167. Epub 2011 May 24. PLoS Negl Trop Dis. 2011. PMID: 21629719 Free PMC article.

7

Potent naphthoquinones against antimony-sensitive and -resistant Leishmania parasites: synthesis of novel α- and nor-α-lapachone-based 1,2,3-triazoles by copper-catalyzed azide-alkyne cycloaddition.

Guimarães TT, Pinto Mdo C, Lanza JS, Melo MN, do Monte-Neto RL, de Melo IM, Diogo EB, Ferreira VF, Camara CA, Valença WO, de Oliveira RN, Frézard F, da Silva EN Jr. Guimarães TT, et al. Eur J Med Chem. 2013 May;63:523-30. doi: 10.1016/j.ejmech.2013.02.038. Epub 2013 Mar 7. Eur J Med Chem. 2013. PMID: 23535320

8

Biophysical and Pharmacological Characterization of Energy-Dependent Efflux of Sb in Laboratory-Selected Resistant Strains of Leishmania (Viannia) Subgenus.

Dos Reis PG, do Monte-Neto RL, Melo MN, Frézard F. Dos Reis PG, et al. Front Cell Dev Biol. 2017 Mar 24;5:24. doi: 10.3389/fcell.2017.00024. eCollection 2017. Front Cell Dev Biol. 2017. PMID: 28393067 Free PMC article.

9

Therapeutic Efficacy of a Mixed Formulation of Conventional and PEGylated Liposomes Containing Meglumine Antimoniate, Combined with Allopurinol, in Dogs Naturally Infected with Leishmania infantum.

Dos Santos CCP, Ramos GS, De Paula RC, Faria KF, Moreira POL, Pereira RA, Melo MN, Tafuri WL, Demicheli C, Ribeiro RR, Azevedo EG, Do Monte-Neto R, Da Silva SM, Frézard F. Dos Santos CCP, et al. Antimicrob Agents Chemother. 2020 Jun 23;64(7):e00234-20. doi: 10.1128/AAC.00234-20. Print 2020 Jun 23. Antimicrob Agents Chemother. 2020. PMID: 32284386 Free PMC article.

10

Exploring direct and indirect targets of current antileishmanial drugs using a novel thermal proteomics profiling approach.

Ibarra-Meneses AV, Corbeil A, Wagner V, Beaudry F, do Monte-Neto RL, Fernandez-Prada C. Ibarra-Meneses AV, et al. Among authors: do monte neto rl. Front Cell Infect Microbiol. 2022 Aug 3;12:954144. doi: 10.3389/fcimb.2022.954144. eCollection 2022. Front Cell Infect Microbiol. 2022. PMID: 35992178 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

19 results

Search Page